Results 101 to 110 of about 699,460 (251)

deusthindwa/Electronic-Data-Capture-for-Large-Scale-Typhoid-Surveillance---STRATAA: edc

, 2020
Electronic data capture systems (EDCs) have the potential to achieve efficiency and quality in collection of multisite data. We quantify volume, time, accuracy and costs of an EDC using large-scale census data from the STRATAA consortium, a comprehensive
Mujadidi, Yama Farooq, Yama Farooq Mujadidi, Thindwa, Deus, Deus Thindwa, Oxford Vaccine Group   +4 more
core   +1 more source

Typhoid vaccine development with a human challenge model.

The Lancet, 2017
Experimental human typhoid fever challenge was first described in 1896 by Wright, who vaccinated two men against typhoid fever and challenged one with what was then known as Salmonella typhosa.1 While challenge models are sometimes controversial, they ...
N. Feasey, M. Levine
semanticscholar   +1 more source

Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

International Journal of Infectious Diseases, 2020
Highlights • This is the first study on the co-administration of typhoid conjugate vaccine (TCV) in West Africa.• Co-administration of TCV with routine vaccines in a typhoid-endemic country was successful.• TCV was safely co-administered at 15 months ...
S. Sirima, A. Ouédraogo, N. Barry, M. Siribie, A. Tiono, I. Nebie’, A. Konaté, G. D. Berges, A. Diarra, Moussa Ouedraogo, I. Soulama, A. Héma, Shrimati Datta, Yuanyuan Liang, Elizabeth T. Rotrosen, J. Tracy, Leslie P. Jamka, K. Neuzil, M. Laurens   +18 more
semanticscholar   +1 more source

“Reactions in Leprosy: Updated Insights Into Pathophysiology, Clinical Spectrum, and Therapeutic Approaches—A Narrative Review”

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Reaction in leprosy is an immune‐mediated acute inflammatory episodes that occur in the natural course of Hansen's disease. Reaction can occur before, during, or after starting multidrug therapy and is a major cause of nerve damage, morbidity, and disability in affected individuals.
Bhaskar Gupta, Manesha Singh, Mohamad Goldust, Kinnor Das, Surajit Gorai, Prajwal Pudasaini, Seema Sitaula, Achyut Pokhrel, Esna Thapa, Sunil Jaiswal   +9 more
wiley   +1 more source

Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan

Vaccine, 2020
Highlights • Post licensure safety data of Typbar-TCV® is not available from a population wide campaign setting.• 207,000 doses of Typbar-TCV were administered in a campaign setting of Hyderabad, Pakistan.• No death, disability or hospitalization ...
F. Qamar, Mohammad Tahir Yousafzai, A. Khaliq, Sultan Karim, H. Memon, Amber Junejo, Inayat Baig, N. Rahman, Shafqat Bhurgry, Hina Afroz, Uzma Sami   +10 more
semanticscholar   +1 more source

Glanders: Past, Present and Future of a Neglected Zoonosis as a Threat in Veterinary and Human Health

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
This review displays a comprehensive overview of glanders, including aetiology, epidemiology, pathogenesis, diagnosis, control strategies and ongoing eradication programs. It has also reviewed differential diagnosis and treatment both in animals and humans as well as organism's antimicrobial properties.
Yahya Kanani, Ahmad Oryan, Abdollah Derakhshandeh   +2 more
wiley   +1 more source

Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.

Clinical Infectious Diseases, 2020
BACKGROUND Typhoid fever prevention and control efforts are critical in an era of rising antimicrobial resistance among typhoid pathogens. India remains one of the highest typhoid disease burden countries, although a highly efficacious typhoid conjugate ...
K. Date, Rahul A. Shimpi, S. Luby, R. N, P. Haldar, Arun Katkar, K. Wannemuehler, V. Mogasale, S. Pallas, Dayoung Song, A. Kunwar, A. Loharikar, V. Yewale, Danish Ahmed, Lily M. Horng, Elisabeth Wilhelm, Sunil Bahl, P. Harvey, S. Dutta, P. Bhatnagar   +19 more
semanticscholar   +1 more source

The Epidemiology of Sickle Cell Disease in Sub‐Saharan Africa: Current Knowledge and Gaps to be Filled

American Journal of Hematology, Volume 101, Issue S1, Page 5-16, April 2026.
What are the available data on incidence & prevalence prognosis risk factors of severity of sickle cell disease in sub‐Saharan Africa? ABSTRACT Sickle Cell Disease (SCD) is highly prevalent in sub‐Saharan Africa. Epidemiological data remain sparse, but regional screening and research initiatives are expanding.
Brigitte Ranque, Leon Tshilolo, Thomas N. Williams   +2 more
wiley   +1 more source

Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage.

, 2006
Vibrio cholerae O1 isolates belonging to the Ogawa serotype, El Tor biotype, harbouring the classical CTX prophage were first isolated in Mozambique in 2004.
Nair, G. Balakrish, Sack, David A., Seidlein, Lorenz von, Lucas, Marcelino E.S., Mondlane, C, Kim, Dong Wook, The Mozambique Cholera Vaccine Demonstration Project Coordinatio, Ansaruzzaman, M, Chun, Jongsik, Nair, G Balakrish, Clemens, John D, Lucas, Marcelino E. S., Ansaruzzaman, M., Mondlane, C., Choi, Seon Young, Song, Manki, Han, Kyung Ho, von Seidlein, Lorenz, Balakrish Nair, G., Lee, Je Hee, Lucas, Marcelino ES, Clemens, John D., Sack, David A   +22 more
core   +1 more source

New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries. [PDF]

, 2012
As more new and improved vaccines become available, decisions on which to adopt into routine programmes become more frequent and complex. This qualitative study aimed to explore processes of national decision-making around new vaccine adoption and to ...
Chavez, E, Biellik, R, Konate, M, Molla, M, Mounier-Jack, S, Griffiths, UK, Burchett, HED, Ongolo-Zogo, P, Uddin, J, Wakasiaka, S, Mills, A, Sarma, H, Gilson, L, Kitaw, Y   +13 more
core   +1 more source